Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gevokizumab by Novartis for Metastatic Colorectal Cancer: Likelihood of Approval
Gevokizumab is under clinical development by Novartis and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...